- Report
- March 2025
- 200 Pages
Global
From €3987EUR$4,490USD£3,484GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1065EUR$1,200USD£931GBP
€1332EUR$1,500USD£1,164GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1421EUR$1,600USD£1,241GBP
€1776EUR$2,000USD£1,552GBP
- Report
- August 2025
- 150 Pages
Global
From €2531EUR$2,850USD£2,211GBP
€3418EUR$3,850USD£2,987GBP
- Report
- July 2025
- 350 Pages
Global
From €4394EUR$4,949USD£3,840GBP
- Report
- June 2025
- 400 Pages
Global
From €4394EUR$4,949USD£3,840GBP
- Report
- April 2025
- 192 Pages
Global
From €4435EUR$4,995USD£3,876GBP
- Report
- July 2025
- 120 Pages
Global
From €5283EUR$5,950USD£4,616GBP
- Report
- December 2025
- 487 Pages
Global
From €5194EUR$5,850USD£4,539GBP
- Report
- December 2025
- 563 Pages
Global
From €5194EUR$5,850USD£4,539GBP
- Report
- November 2025
- 185 Pages
Global
From €3996EUR$4,500USD£3,491GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,164GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,164GBP
- Report
- July 2025
- 175 Pages
Global
From €3987EUR$4,490USD£3,484GBP
- Report
- July 2024
- 150 Pages
Global
From €5283EUR$5,950USD£4,616GBP
- Report
- May 2023
- 260 Pages
Global
From €2353EUR$2,650USD£2,056GBP
- Report
- June 2024
- 200 Pages
Global
From €5647EUR$6,360USD£4,935GBP
€7059EUR$7,950USD£6,168GBP
- Report
- June 2024
- 200 Pages
Global
From €5647EUR$6,360USD£4,935GBP
€7059EUR$7,950USD£6,168GBP
- Report
- January 2022
- 60 Pages
Global
From €2806EUR$3,160USD£2,452GBP
€3507EUR$3,950USD£3,065GBP
- Report
- May 2024
- 137 Pages
Global
From €4905EUR$5,524USD£4,286GBP
€5770EUR$6,499USD£5,042GBP

The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more